Literature DB >> 11118805

Familial moyamoya disease in Caucasians.

N Shetty-Alva1, S Alva.   

Abstract

There are few reports of moyamoya disease (MMD) in the Caucasian population and even fewer descriptions of the natural history of the disease. The study reports a 12-year follow-up of two white male siblings with MMD. Although both brothers had a persistently abnormal electroencephalogram and a learning disorder, the siblings recovered on aspirin and antiepileptic therapy with minimal neurologic residua. The occurrence of MMD in these siblings contributes to the evidence that MMD has a hereditary basis in Caucasians, as well as the Japanese. Even with the use of conservative measures, children may still have persistent yet minor cerebrovascular insults. In addition to the two patients discussed, this study reviewed the literature on all cases of MMD reported within families. Future follow-up studies are required to determine the natural history and the appropriate medical and surgical management of MMD.

Entities:  

Mesh:

Year:  2000        PMID: 11118805     DOI: 10.1016/s0887-8994(00)00215-0

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  4 in total

1.  Familial occurrence of moyamoya disease: a clinical study.

Authors:  Ho Jun Seol; Kyu-Chang Wang; Seung-Ki Kim; Yong-Seung Hwang; Ki Joong Kim; Byung-Kyu Cho
Journal:  Childs Nerv Syst       Date:  2006-03-25       Impact factor: 1.475

2.  Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  James F Meschia; Cheryl Bushnell; Bernadette Boden-Albala; Lynne T Braun; Dawn M Bravata; Seemant Chaturvedi; Mark A Creager; Robert H Eckel; Mitchell S V Elkind; Myriam Fornage; Larry B Goldstein; Steven M Greenberg; Susanna E Horvath; Costantino Iadecola; Edward C Jauch; Wesley S Moore; John A Wilson
Journal:  Stroke       Date:  2014-10-28       Impact factor: 7.914

3.  Moyamoya disease in which pentazocine treatment caused cerebral infarction.

Authors:  Yoshinori Matsuoka; Makoto Hashizume
Journal:  BMJ Case Rep       Date:  2010-11-09

4.  Clinical features, prothrombotic risk factors, and long-term follow-up of eight pediatric Moyamoya patients.

Authors:  Burak Tatlı; Barış Ekici; Altay Sencer; Serra Sencer; Kubilay Aydın; Nur Aydınlı; Mine Calışkan; Meral Ozmen; Talat Kırış
Journal:  J Clin Neurol       Date:  2012-06-29       Impact factor: 3.077

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.